FREE STANDARD SHIPPING on orders over $99+
free priority shipping on ORDERS OVER $199+
Numstat Antiseptic Numbing Wipes
1 Prep Pad
$0.79
Out of stock
NUMSTAT Antiseptic Numbing Wipes for Needle Pain Relief, 2-In-1 Formula with Benzocaine, Isopropyl Alcohol and Menthol
Relieves Needle Pain - You can now prepare for needle pain with NUMSTAT. If applied in advance to the area, NUMSTAT’s proprietary blend will be there to relieve the pain with 15% Benzocaine and 1% Menthol, while it cleans and kills germs reducing the risk of infection with 71% Isopropyl Alcohol.
Fast Acting Antiseptic Prep Wipe for Needle Sticks - Applied in advance to the injection site, NUMSTAT’s prep pad cleans, kills germs, and relieves the pain of needle sticks with fast-acting Benzocaine. Simply apply the pad solution to the skin, gently rub into the skin for 60 seconds and let dry. NUMSTAT helps reduce the pain of needle sticks. Test the injection site for effect by touching the area before performing the procedure.
Convenient, Single-Use Prep Pad - NUMSTAT is supplied in convenient individual foil pouches that you can just tear open. The NUMSTAT solution on the non-woven prep pad works fast to prepare the site. It is durable yet soft and non-abrasive to your skin. NUMSTAT can go anywhere and fits in your pocket, purse, travel bag or first-aid kit.
Developed by Doctors - Many people are afraid of needles and the pain they bring. Intense fear of needle sticks can cause people to delay or avoid necessary medical care such as diabetic testing. NUMSTAT was developed by doctors to help people with the fear and pain of needle sticks. Applied in advance, NUMSTAT relieves needle pain.
Optitide Research supplies research-grade peptides exclusively to qualified research professionals and institutions in the USA.
Contact
Newsletter
info@optitideresearch.com
209-624-0715
© 2026. All rights reserved.


All materials offered by Optitide Research are supplied strictly for laboratory research and development use. These products are not intended for human ingestion or clinical application. The content and claims presented on this website have not been reviewed or approved by the U.S. Food and Drug Administration (FDA). None of the statements or products provided by Optitide Research are designed to diagnose, mitigate, treat, cure, or prevent any disease.
Optitide Research operates solely as a product supplier. The company is not a compounding pharmacy or chemical compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the same Act.
